Data Science in the News

UC Merced students work with LLNL mentors on potential new drugs to combat COVID-19

June 30, 2022- 
Students from the University of California, Merced worked with mentors at LLNL to identify drug compounds that could be used to treat COVID-19 during a two-week Data Science Challenge (DSC) that concluded on June 6. For the first time in the DSC series since the COVID-19 pandemic began in 2020, Lab mentors visited the college campus to provide in-person guidance for five teams of UC Merced...

LLNL’s Brase discusses advances by ATOM in accelerating drug discovery pipeline

June 7, 2022- 
The private-public Accelerating Therapeutic Opportunities in Medicine (ATOM) consortium is showing “significant” progress in demonstrating that HPC and M) tools can speed up the drug discovery process, said Jim Brase, ATOM co-lead and LLNL’s deputy associate director for data science. The consortium currently boasts more than a dozen member organizations, including national laboratories...

CASC team wins best paper at visualization symposium

May 25, 2022- 
A research team from LLNL’s Center for Applied Scientific Computing won Best Paper at the 15th IEEE Pacific Visualization Symposium (PacificVis), which was held virtually on April 11–14. Computer scientists Harsh Bhatia, Peer-Timo Bremer, and Peter Lindstrom collaborated with University of Utah colleagues Duong Hoang, Nate Morrical, and Valerio Pascucci on “AMM: Adaptive Multilinear Meshes.”...

Kevin McLoughlin applies computational biology to complex problems

May 17, 2022- 
Kevin McLoughlin has always been fascinated by the intersection of computing and biology. His LLNL career encompasses award-winning microbial detection technology, a COVID-19 antiviral drug design pipeline, and work with the ATOM consortium. The appeal for him in these projects lies at the intersection of computing and biology. “I love finding ways to visualize data that reveal relationships...

Machine learning model finds COVID-19 risks for cancer patients

March 10, 2022- 
A new study by researchers at LLNL and the University of California, San Francisco, looks to identify cancer-related risks for poor outcomes from COVID-19. Analyzing one of the largest databases of patients with cancer and COVID-19, the team found previously unreported links between a rare type of cancer—as well as two cancer treatment-related drugs—and an increased risk of hospitalization...

LLNL team models COVID-19 disease progression and identifies risk factors

Feb. 15, 2022- 
An LLNL team has developed a comprehensive dynamic model of COVID-19 disease progression in hospitalized patients, finding that risk factors for complications from the disease are dependent on the patient’s disease state. Using a machine learning algorithm on a dataset of electronic health records from more than 1,300 hospitalized COVID-19 patients with ProMedica — the largest health care...

LLNL joins Human Vaccines Project to accelerate vaccine development and understanding of immune response

Oct. 21, 2021- 
LLNL has joined the international Human Vaccines Project (HVP), bringing Lab expertise and computing resources to the consortium to aid development of a universal coronavirus vaccine and improve understanding of immune response. The HVP is a nonprofit, public-private partnership with a mission to decode the human immune system and accelerate the development of vaccines and immunotherapies...

Tackling the COVID-19 pandemic

Oct. 11, 2021- 
To help the U.S. fight the COVID-19 pandemic, LLNL did what it does best: quickly bring together interdisciplinary teams and diverse technologies to address urgent national challenges. This effort includes applying advanced high-performance computing resources to biological research and anayzing complicated computer models and enormous datasets. Read more in Science & Technology Review.

Visualization software stands the test of time

Sept. 13, 2021- 
In the decades since LLNL’s founding, the technology used in pursuit of the Laboratory’s national security mission has changed over time. For example, studying scientific phenomena and predicting their behaviors require increasingly robust, high-resolution simulations. These crucial tasks compound the demands on high-performance computing hardware and software, which must continually be...

COVID-19 detection and analysis with Nisha Mulakken (VIDEO)

June 7, 2021- 
LLNL biostatistician Nisha Mulakken has enhanced the Lawrence Livermore Microbial Detection Array (LLMDA) system with detection capability for all variants of SARS-CoV-2. The technology detects a broad range of organisms—viruses, bacteria, archaea, protozoa, and fungi—and has demonstrated novel species identification for human health, animal health, biodefense, and environmental sampling...

Laser-driven ion acceleration with deep learning

May 25, 2021- 
While advances in machine learning over the past decade have made significant impacts in applications such as image classification, natural language processing and pattern recognition, scientific endeavors have only just begun to leverage this technology. This is most notable in processing large quantities of data from experiments. Research conducted at LLNL is the first to apply neural...

The data-driven future of extreme physics

May 19, 2021- 
By applying modern machine learning and data science methods to “extreme” plasma physics, researchers can gain insight into our universe and find clues about creating a limitless amount of energy. In a recent perspective published in Nature, LLNL scientists and international collaborators outline key challenges and future directions in using machine learning and other data-driven techniques...

COVID-19 HPC Consortium reflects on past year

April 1, 2021- 
COVID-19 HPC Consortium scientists and stakeholders met virtually on March 23 to mark the consortium’s one-year anniversary, discussing the progress of research projects and the need to pursue a broader organization to mobilize supercomputing access for future crises. The White House announced the launch of the public-private consortium, which provides COVID-19 researchers with free access to...

Model for COVID-19 drug discovery a Gordon Bell finalist

Nov. 17, 2020- 
A machine learning model developed by a team of LLNL scientists to aid in COVID-19 drug discovery efforts is a finalist for the Gordon Bell Special Prize for High Performance Computing-Based COVID-19 Research. Using Sierra, the world’s third fastest supercomputer, LLNL scientists produced a more accurate and efficient generative model to enable COVID-19 researchers to produce novel compounds...

DOE announces five new energy projects at LLNL

Nov. 13, 2020- 
The DOE today announced two rounds of awards for the High Performance Computing for Energy Innovation Program HPC4EI), including five projects at LLNL. HPC4EI connects industry with the computational resources and expertise of the DOE national laboratories to solve challenges in manufacturing, accelerate discovery and adoption of new materials and improve energy efficiency. The awards were...

What put LLNL at the center of U.S. supercomputing in 2020?

Nov. 12, 2020- 
The HPC world is waiting for the next series of transitions to far larger machines with exascale capabilities. By this time next year, the bi-annual ranking of the Top500 most powerful systems will be refreshed at the top as Frontier, El Capitan, Aurora, and other DOE systems come online. While LLNL was already planning around AI acceleration for its cognitive simulation aims and had a number...

Looking ahead to SC20

Oct. 27, 2020- 
Lawrence Livermore heads to the 32nd annual Supercomputing Conference (SC20) held virtually throughout November 9–19. Be sure to follow LLNL Computing (@Livermore_Comp) on Twitter with these hashtags: #LLNLatSC, #SC20, #MoreThanHPC. The Department of Energy (@NatLabsHPC) will also tweet during the event. Much of the content is pre-recorded and will remain available online for six months...

AI gets a boost via LLNL, SambaNova collaboration

Oct. 20, 2020- 
LLNL has installed a state-of-the-art artificial intelligence (AI) accelerator from SambaNova Systems, the National Nuclear Security Administration (NNSA) announced today, allowing researchers to more effectively combine AI and machine learning (ML) with complex scientific workloads. LLNL has begun integrating the new AI hardware, SambaNova Systems DataScale™, into the NNSA’s Corona...

LLNL, ANL and GSK provide early glimpse into Cerebras AI system performance

Oct. 13, 2020- 
AI chip and systems startup Cerebras was one of many AI companies showcased at the AI Hardware Summit which concluded last week. Cerebras invited collaborators from LLNL, Argonne National Laboratory, and GlaxoSmithKline to talk about their early work on Cerebras machines and future plans. Livermore Computing's CTO Bronis de Supinski said, “We have this vision for performing cognitive...

Harsh Bhatia uses scientific visualization to see the unseen

Oct. 6, 2020- 
Harsh Bhatia is a computer scientist at the Center for Applied Scientific Computing (CASC) where he has made a name for himself in data analysis, scientific visualization, and machine learning. His wide range of projects include applying topological techniques to understand the behavior of lithium ions, generating topological representations of aerodynamics data, and analyzing and visualizing...